Takeda Pharmaceutical Company Limited Weighted Average Exercise Price Of Share Options In Share-based Payment Arrangement Exercised During Period At Date Of Exercise
Takeda Pharmaceutical Company Limited (TKPHF) reported Weighted Average Exercise Price Of Share Options In Share-based Payment Arrangement Exercised During Period At Date Of Exercise of JPY 4.68 thousand for the 12-month period ending 2019-03-31, per its 20-F filed 2019-06-27.
Discontinued › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise · last filed 2019-06-27
| Period end | Weighted Average Exercise Price Of Share Options In Share-based Payment Arrangement Exercised During Period At Date Of Exercise 12 month |
|---|---|
| 2019-03-31 | 4.68K JPY 20-F · filed 2019-06-27 |
| 2018-03-31 | 5.96K JPY 20-F · filed 2019-06-27 |
| 2017-03-31 | 4.94K JPY 20-F · filed 2019-06-27 |